Benzinga | Dec 15, 2020 03:12PM EST

'$PIRS granted US Patent #10865250 for "Anti-cancer fusion polypeptide". For the treatment/prevention of a variety of tumors. No Press Release Yet.' - Tweet From Patent_Stocks

https://twitter.com/US_Patent_Plays/status/1338939293084094465

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=10865250.PN.&OS=PN/10865250&RS=PN/10865250